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Background: Hemodynamic optimization improves postoperative outcomes in high-risk surgery patients. The 
monitoring of cardiac output (CO) and dynamic parameters of fluid responsiveness can guide hemodynamic 
optimization. We conducted a survey to assess the current hemodynamic monitoring and management practices of 
Korean anesthesiologists during high-risk surgery.
Methods: E-mails containing a link to our survey, which consisted of 33 questions relating to hemodynamic monitoring 
during high-risk surgery, were sent to 3,943 members of the Korean Society of Anesthesiologists (KSA). The survey web 
page was open from December 30, 2011 to March 31, 2012.
Results: A total of 139 anesthesiologists responded during the survey period. Invasive arterial pressure (97.2%) and 
central venous pressure (93.4%) were routinely monitored. CO was monitored in 58.5% of patients; stroke volume 
variations were monitored in 50.9% of patients. However, CO was consistently optimized by < 20% of anesthesiologists. 
An arterial pressure waveform-derived CO monitor was the most frequently used device to monitor CO (79.0%). Blood 
pressure, urine output, central venous pressure, and clinical experience were considered to be the best indicators of 
volume expansion than CO or dynamic parameters of fluid responsiveness. 
Conclusions: The survey revealed that KSA members frequently monitor CO and dynamic parameters of fluid 
responsiveness during high-risk surgery. However, static indices were used more often to judge volume expansion. The 
current study reveals that CO is not frequently optimized despite the relatively high incidence of CO monitoring during 
high-risk surgery in Korea. (Korean J Anesthesiol 2013; 65: 19-32)
Key Words: Cardiac output, Hemodynamics, Intraoperative, Monitoring, Treatment outcome.
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Introduction
Hemodynamic management in high-risk surgery patients 
is a challenge for anesthesiologists. Clinical variables such as 
arterial blood pressure (BP), heart rate (HR), and urine output 
(UO) do not detect tissue hypoperfusion during the early stage 
of surgery. Furthermore, static parameters such as central 
venous pressure (CVP) and pulmonary capillary wedge pressure 
(PCWP) reportedly provide little information regarding preload 
or fluid responsiveness [1,2]. Fluid management focusing on 
these parameters may under- or over-hydrate patients, which 
can increase postoperative morbidity [3]. Initially, the goal of 
hemodynamic intervention was to maintain supra-normal 
oxygen delivery (DO2) by maintaining a certain level of flow-
related hemodynamic variables, including cardiac output (CO) 
by administering fluid, drugs, or blood products. Following a 
historical report showing that an increase in CO measured using 
a pulmonary artery catheter (PAC) improved postoperative 
outcomes [4], several studies have demonstrated the benefits of 
a hemodynamic optimization protocol [5-7]. 
Previously, the hemodynamic management of CO or DO2 
required invasive techniques such as a PAC; however, tech-
nological advances have made minimally or noninvasive CO 
monitoring techniques readily available [8-10] for clinicians 
to use goal-directed hemodynamic management in high-risk 
surgery patients. The findings of recent meta-analyses con firmed 
that preemptive hemodynamic intervention or the maintenance 
of tissue perfusion decreased postoperative mortality, morbidity, 
and organ failure [11,12]. Furthermore, dynamic parameters 
of fluid responsiveness such as stroke volume variation (SVV), 
pulse pressure variation (PPV), and the pleth variability index 
(PVI) can reveal variations in stroke volume induced by 
cardiopulmonary interactions during mechanical ventilation 
and identify patients who need fluid administration to increase 
their CO [13-15]. Thus, minimally invasive CO monitors and 
surrogates for predicting fluid responsiveness are available for 
anesthesiologists as routine hemo dynamic monitors to optimize 
the hemodynamic status of high-risk surgery patients. However, 
a previous survey of American and European anesthesiologists 
showed that a con siderable gap exists between the perceived 
benef its  of  hemo dynamic optimization and cl inical 
implementation of the avail able technology [16]. 
The present survey aimed to assess current hemodynamic 
monitoring and management of high-risk surgery patients 
among South Korean anesthesiologists. 
Materials and Methods
Our Institutional Review Board approved the survey. The 
target population was board-certified members of the Korean 
Society of Anesthesiologists (KSA). The KSA office e-mail 
database includes the e-mail addresses of 3,943 board-certified 
anesthesiologists registered with the organization, but about 
1,000 addresses are invalid. After excluding invalid addresses, 
the remainder includes members who no longer practice 
anesthesia (e.g., pain clinicians, honorary members, and retired 
members). All e-mails were sent by the KSA and no e-mail 
addresses were provided to the authors. Two methods were 
used to distribute the survey to maximize the response rate 
and participation. The initial invitation to participate appeared 
in the KSA e-newsletter. One week later, an e-mail inviting 
participation was sent to each of the 3,943 members of the KSA. 
Finally, a follow-up e-mail was sent to respondents and non-
respondents 6 weeks after the first e-mail; thus, a total of three 
e-mail invitations to join the study were issued. 
The invitation cover letter included the purpose of the survey, 
the name and affiliation of the researcher, and the potential 
benefit of the survey. The cover letter encouraged respondents to 
participate, and a link to the survey web page was shown at the 
end of the letter (www.surveymonkey.com). The survey was open 
for 3 months, from December 30, 2011 to March 31, 2012.
Survey description
We adopted the definition of a high-risk surgery patient used 
in previous studies for noncardiac surgery [16,17]. The criteria 
included patients aged 18 years or older presenting for major 
surgery with an expected duration of more than 1.5 h and having 
at least two of the following:
1. Cardiac or respiratory illness resulting in functional 
limitations
2. Extensive surgery planned for carcinoma involving bowel 
anastomosis
3. Predictable acute massive blood loss (> 2.5 L)
4. Aged > 70 years with a functional limitation in one or 
more organ systems
5. Septicemia (positive blood culture or septic focus)
6. Respiratory failure (PaO2 < 60 mmHg on FiO2 > 0.4; that 
is, a PaO2:FiO2 ratio of < 150 mmHg or ventilation > 48 h)
7. Acute abdominal catastrophe (e.g., pancreatitis, perforated 
viscous, or gastro-intestinal bleed)
8. Acute renal failure (urea > 20 mmol/L and creatinine 
> 260 μmol/L)
9. Surgery for abdominal aortic aneurysm
10. Disseminated malignancy
The survey contained 33 questions divided into two parts 
consisting of respondent demographic data (14 questions) and 
clinical experience in the anesthetic management of high-risk 
surgical patients (19 questions). The questionnaire was identical to 
that published in 2011 with the exception that the present survey 
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asked for the city in which the respondent practiced [16]. The full 
questionnaire used in this survey is shown in the Appendix. 
Questions regarding the current practice of 
hemodynamic monitoring in high-risk surgery patients
Routine hemodynamic monitoring and hemodynamic 
optimization
Questions were asked concerning the respondent’s routine 
hemodynamic monitoring practice and the intraoperative 
frequency with which they optimized parameters of hemo-
dynamic monitoring such as invasive arterial pressure (IAP), 
CVP, CO, mixed venous oxygen saturation (Svo2), central 
venous oxygen saturation (Scvo2), and dynamic parameters of 
fluid responsiveness such as PPV, systolic pressure variation 
(SPV), and plethysmographic waveform variation. The 
respondents were asked which methods they used to evaluate 
the dynamic parameters of fluid responsiveness, and at what 
point during surgery optimization procedures were performed. 
CO monitoring
Respondents were asked what technique they currently used 
to monitor CO, and if they did not routinely monitor CO, they 
were asked to indicate why. 
Volume management
Four questions on volume management included diagnostic 
indicators of volume expansion, an assessment of the 
hemodynamic effect of volume expansion, the best predictor 
of volume expansion, and the type of fluid used for volume 
expansion.
Other questions
We asked the respondents whether they believed oxygen 
delivery to tissues was of major importance and whether they 
felt their current hemodynamic management approach could be 
improved. 
Statistics
Respondents who did not perform or directly supervise 
anes thesia for high-risk patients were excluded from the 
analysis. The data are expressed as the number of respondents 
and percentages. Results from a previously published survey 
conducted among American Society of Anesthesiology (ASA) 
and European Society of Anesthesiology (ESA) members 
were included for comparison [16]. All statistical tests were 
conducted using the Statistical Package for the Social Sciences 
version 14.0 (SPSS Inc., Chicago, IL, USA). 
Results
We received 139 responses from KSA members. Of those, 22 
indicated that they did not administer or supervise anesthesia 
for high-risk patients. Among the remaining 117 respondents, 
6 did not answer any further questions and were excluded from 
the analysis. The remaining 111 respondents were included 
in the analysis, and, of those, 70 (63%) completed the entire 
questionnaire. 
Demographic data
Most of the respondents worked at university (79%) or general 
(19%) hospitals. In a typical work week, they reported admini-
stering or directly supervising anesthesia for high-risk patients 1-5 
times (61%), 6-10 times (19%), or > 11 times (10%). More than 
half reported that they administered anesthesia for various types 
of surgery. We found that 13% of the respondents were cardiac 
anesthesiologists and 9% were transplant anesthesiologists.
Furthermore, 30% of the respondents worked at a hospital 
with more than 1,000 beds, 60% worked at hospitals with 500-
1,000 beds, 59% worked in hospitals with > 40 intensive care unit 
beds, 50% of respondents finished training after the year 2000, 
and 60% of the respondents completed fellowship training. The 
most frequent fellowship was cardiac anesthesia (33%) followed 
by critical care, pain, research, and transplant anesthesia. About 
70% of respondents practiced in Seoul, Gyeonggi, and Busan.
Questions regarding the current practice of 
hemodynamic monitoring in high-risk surgery patients
Two-thirds (66%) of 109 respondents reported that their 
institution or group did not have a written protocol, care guide, 
Fig. 1. Does your institution or group have a written protocol, care 
guide, or statement concerning hemodynamic management in this 
setting?
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or statement concerning hemodynamic management in high-
risk surgery patients; 10% answered that they were unsure or 
did not know, whereas 24% reported that a protocol was in 
place (Fig. 1).
Routine hemodynamic monitoring and hemodynamic 
optimization
The most commonly reported methods for routine hemo-
dynamic monitoring were IAP (97%) and CVP (93%), followed 
by CO (59%) and SVV (51%) (Table 1). 
The frequency of intraoperative hemodynamic optimization 
for > 50% of the time for each parameter was highest for BP 
followed by CVP and CO (Fig. 2). In contrast, no respondent 
reported optimizing Scvo2 or Svo2 > 50% of the time. Approxi-
mately 60% of the respondents reported that they optimized 
hemodynamics during surgery and after the induction of 
anesthesia. Half of the respondents regarded the intraoperative 
period as the most critical time for hemodynamic optimization.
CO monitoring
The most frequently used CO monitoring device was the 
Flotrac/Vigileo monitor (79%) followed by the Swan Ganz 
catheter (52%), transesophageal echocardiography (TEE, 32%), 
and esophageal Doppler (13%) (Fig. 3). The two main reasons 
Table 1. What Hemodynamic Monitoring Do You Routinely Use for the Management of High-risk Surgery Patients? (Please, Mark All That Apply)
Answer options
KSA respondents (n = 106) ASA respondents (n = 237) ESA respondents (n = 195)
Response percent Response percent Response percent
Invasive arterial pressure
Central venous pressure
Non-invasive arterial pressure
Cardiac output
Pulmonary capillary wedge pressure
Transesophageal echocardiography
Systolic Pressure Variation
Plethysmographic Waveform Variation
Pulse Pressure Variation
Mixed venous saturation (SvO2)
Central venous saturation (ScvO2)
Oxygen delivery (DO2)
Stroke Volume Variation
Near infrared spectroscopy
Global end diastolic volume
97.2%
93.4%
64.2%
58.5%
25.5%
31.1%
28.3%
19.8%
29.2%
18.9%
24.5%
12.3%
50.9%
14.2%
5.7%
95.4%
72.6%
51.9%
35.4%
30.8%
28.3%
20.3%
17.3%
15.2%
14.3%
12.7%
6.3%
6.3%
4.6%
2.1%
89.7%
83.6%
53.8%
34.9%
14.4%
19.0%
23.6%
17.9%
25.6%
15.9%
33.3%
14.4%
21.5%
5.1%
8.2%
KSA: Korean Society of Anesthesiologists, ASA: American Society of Anesthesiology respondents, ESA: European Society of Anaesthesiology 
respondents. We obtained permission by the publisher to use data from ASA and ESA.
Fig. 2. How frequently do you try to optimize arterial pressure, central 
venous pressure, and cardiac output in this setting? Fig. 3. What technique do you use to monitor cardiac output?
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for not monitoring CO in high-risk surgery patients were a 
preference for measuring dynamic parameters rather than 
the direct measurement of CO (37%) and the invasiveness of 
current CO monitoring techniques (32%). Moreover, 19% of the 
respondents felt that CO monitoring did not provide additional 
clinically relevant information (Table 2). However, 94% of the 
respondents indicated that oxygen delivery to tissues was of 
major importance during high-risk surgery.
Volume management
More than 80% of the respondents replied that BP (85%) 
and UO (81%) were diagnostic indicators of volume expansion, 
followed by CVP (73%), clinical experience (71%), and CO 
(57%). Dynamic parameters were regarded as better indicators 
than TEE and PCWP (51%) (Table 3). The respondents 
used primarily classic parameters such as increased BP 
and UO, decreased HR, and clinical experience to assess 
the hemodynamic effect of volume expansion. Half of the 
respondents routinely measured CO to assess the effects of 
volume expansion, and SVV was used more frequently than 
PPV or SPV among the dynamic parameters (Table 4). More 
respondents felt that SVV (20%) or CO (17%) was a better 
predictor of volume expansion than BP (9%) or CVP (3%) (Table 5). 
The dynamic parameters of fluid responsiveness were 
measured by eyeballing (44%), automatic measurement using 
specific software (41%), and manual calculations (16%). 
The most commonly used fluid for volume expansion was 
hydroxyethyl starch (73%), followed by crystalloid (18%) and 
blood products (7%).
Finally, 88% of the respondents believed that their current 
hemodynamic management approach could be improved. 
Table 2. If You Do Not Monitor Cardiac Output Routinely in These Patients, What Are the Main Reasons for not Monitoring It? (Please, Mark All 
That Apply)
Answer options
KSA respondents
(n = 81)
ASA respondents     
(n = 157)
ESA respondents
    (n = 142)
Response percent Response percent Response percent
I use dynamic parameters of fluid responsiveness (Pulse Pressure 
Variations, Systolic Pressure Variations, Plethysmographic Waveform 
Variations) as surrogates for cardiac output monitoring
Available cardiac output monitoring solutions are too invasive
Cardiac output monitoring does not provide any additional clinically 
relevant information in this setting
I use SvO2 and/or ScVO2 as surrogates for cardiac output monitoring
Available cardiac output monitoring solutions are unreliable
37.0%
32.1%
18.5%
7.4%
4.9%
54.1%
48.4%
24.2%
13.4%
8.3%
60.6%
26.8%
14.1%
26.1%
15.5%
KSA: Korean Society of Anesthesiologists, ASA: American Society of Anesthesiology respondents, ESA: European Society of Anaesthesiology 
respondents. We obtained permission by the publisher to use data from ASA and ESA.
Table 3. What Are Your Indicators for Volume Expansion in This Setting (Diagnostic Tools)? (Please, Mark All That Apply)
Answer options
KSA respondents (n = 73) ASA respondents (n = 209) ESA respondents (n = 165)
Response percent Response percent Response percent
Blood pressure
Urine output
Clinical experience
Central venous pressure
Cardiac output
Pulse Pressure Variation or Systolic Pressure Variation
Transesophageal echocardiography
Pulmonary capillary wedge pressure
Plethysmographic Waveform Variation
Stroke Volume Variation
Mixed venous saturation (SvO2)
Global end diastolic volume
Central venous saturation (ScvO2)
84.9%
80.8%
71.2%
72.6%
57.5%
50.7%
34.2%
27.4%
15.1%
50.7%
13.7%
5.5%
15.1%
88.5%
83.3%
77.5%
70.8%
49.3%
45.0%
43.5%
38.8%
25.4%
19.1%
18.7%
10.5%
10.0%
77.6%
77.0%
64.8%
64.2%
53.3%
55.8%
28.5%
24.2%
25.5%
36.4%
21.8%
17.0%
34.5%
KSA: Korean Society of Anesthesiologists, ASA: American Society of Anesthesiology respondents, ESA: European Society of Anaesthesiology 
respondents. We obtained permission by the publisher to use data from ASA and ESA.
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Discussion
The results of our survey indicate that significant numbers 
of KSA respondents routinely monitor CO in high-risk surgery 
patients. However, CO was consistently optimized by < 20% of 
anesthesiologists, demonstrating a gap between the monitoring 
and optimization of CO in high-risk surgery patients. Further-
more, the respondents considered BP, CVP, HR, UO, and clinical 
experience to be better indicators or surrogates of volume 
expansion than CO or dynamic parameters of fluid respon-
siveness. The present results indicate that CO optimization is 
not widely used by Korean anesthesiologists, despite substantial 
evidence showing that CO optimization improves postoperative 
outcomes in high-risk surgery patients [11,12]. 
The present survey was conducted to assess current hemo-
dynamic monitoring practices, particularly CO monitoring 
and optimization, in high-risk surgery patients in South Korea. 
Besides IAP, CVP, and non-invasive BP, we found that more 
than half of the KSA respondents routinely monitored CO (59%) 
and SVV (51%). The monitoring frequencies of CO and SVV 
in our survey were higher than those reported in a survey by 
the ASA and ESA, in which routine CO monitoring was done 
by 35% of ASA and ESA respondents, and SVV was routinely 
monitored by 6% of ASA and 22% of ESA respondents [16]. 
This unexpectedly high frequency of CO and SVV monitoring 
may be attributable to the high rate (79%) of Flotrac/Vigileo 
monitor use. We speculate that the minimal invasiveness 
of the system, which uses an existing arterial catheter and 
simultaneously monitors SVV, may have contributed to the high 
frequency of CO monitoring in high-risk surgery patients. 
Our results show that more respondents optimized BP than 
CO or dynamic parameters. Despite the relatively high frequency 
of monitoring CO, few respondents in the present study reported 
optimizing CO for > 50% of the intraoperative time, revealing 
a discrepancy between CO monitoring and optimization. This 
discrepancy is consistent with the survey findings of the ASA 
Table 4. How Do You Routinely Assess the Hemodynamic Effects of Volume Expansion in This Setting?
Answer options
KSA respondents
(n = 72)
ASA respondents     
(n = 203)
ESA respondents     
(n = 162)
Response percent Response percent Response percent
Increase in blood pressure
Increase in urine output
Decrease in heart rate
Increase in cardiac output
Decrease in pulse pressure variation or systolic pressure variation
Decrease in plethysmographic waveform variation
Increase in mixed venous saturation (SvO2)
Decrease in stroke volume variation
Increase in central venous saturation (ScvO2)
70.8%
75.0%
68.1%
51.4%
43.1%
22.2%
11.1%
56.9%
13.9%
92.1%
84.7%
74.4%
59.1%
56.7%
28.6%
22.2%
21.7%
19.2%
75.3%
73.5%
75.3%
54.3%
54.9%
25.9%
18.5%
35.2%
27.8%
KSA: Korean Society of Anesthesiologists, ASA: American Society of Anesthesiology respondents, ESA: European Society of Anaesthesiology 
respondents. We obtained permission by the publisher to use data from ASA and ESA.
Table 5. In Your Opinion, What Best Predicts an Increase in Cardiac Output Following Volume Expansion?
Answer options
KSA respondents (n = 71) ASA respondents  (n = 190) ESA respondents (n = 158)
Response percent Response percent Response percent
Transesophageal echocardiography
Cardiac output
Blood pressure
Pulse pressure variation or systolic pressure variation
Mixed venous saturation (SvO2)
Stroke volume variation
Clinical experience
Pulmonary capillary wedge pressure
Central venous saturation (ScvO2)
Central venous pressure
Global end diastolic volume
Plethysmographic waveform variations
12.7%
16.9%
8.5%
12.7%
5.6%
19.7%
11.3%
5.6%
  0%
2.8%
0%
4.2%
26.8%
21.1%
14.2%
12.1%
7.9%
5.8%
5.3%
2.1%
2.1%
1.1%
1.1%
0.5%
17.7%
20.9%
5.7%
12.0%
5.7%
21.5%
3.2%
3.2%
1.9%
3.2%
3.8%
1.3%
KSA: Korean Society of Anesthesiologists, ASA: American Society of Anesthesiology respondents, ESA: European Society of Anesthesiology 
respondents. We obtained permission by the publisher to use data from ASA and ESA.
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and ESA [16]. While evidence indicates that CO optimization 
or maximization improves the outcome of high-risk surgery 
patients in terms of postoperative complications, mortality, 
and hospital stay [18-20], our survey demonstrated that many 
anesthesiologists in Korea do not use a routine CO optimization 
strategy in their clinical practice. This is an opportunity for 
improvement. As stated by Dr. Michael Pinsky, “No monitoring 
tool, no matter how accurate, by itself has improved patient 
outcome” [21], suggesting that only the actual practice of CO 
optimization has the potential to improve outcome. Several 
explanations for this gap are as follows. First, the benefits of CO 
optimization are not universally accepted; some believe that 
CO maximization is unnecessary or may be harmful [22,23]. 
Second, because the benefits of hemodynamic optimization 
appear post-surgery (e.g., reductions in morbidity or the 
length of hospitalization), anesthesiologists, particularly those 
not involved in postoperative care, may not be aware of or 
concerned about patient outcomes during the intraoperative 
period [24]. Third, flow-based, protocol-oriented fluid manage-
ment is labor-intensive and requires the frequent assessment of 
fluid responsiveness after each administration. The procedure 
is difficult to perform routinely in the busy operating room 
environment. Finally, the absence of guidelines or a protocol 
may contribute to an anesthesiologist’s reluctance to adopt this 
approach. The development of a protocol and quality assurance 
process to improve postoperative outcomes may be helpful in 
resolving these uncertainties [25].
Identifying responders and non-responders to fluid admini-
stration is important to guide fluid therapy in high-risk surgery 
patients. Dynamic indices are now well accepted to be better 
predictors of fluid responsiveness than static indices in patients 
with mechanical ventilation [26]. The respondents in the current 
survey also recognized dynamic indices such as SVV as the best 
predictors of fluid responsiveness; only 3% believed that CVP is 
an accurate predictor. This observation is of major significance 
for at least two reasons. First, while Korean anesthesiologists 
understand that CVP is a weak predictor of fluid responsiveness, 
93% still monitor this variable during high-risk surgery, which 
is at least 20% higher than what had been reported by ASA 
and ESA members. Second, Korean anesthesiologists merely 
monitor CVP rather than try to optimize it, which raises the 
question of why CVP is still monitored in this setting. Recent 
quality improvement programs implementing CO optimization 
during major surgery have shown that this approach decreases 
the use of central venous catheters, which may, in turn, decrease 
the incidence of central line-related complications [9]. The 
results of our study indicate that many anesthesiologists in 
Korea still rely heavily on CVP in fluid management despite 
their recognition that dynamic parameters are better predictors 
of fluid responsiveness. Familiarity with traditional variables 
and a lack of implementation of formal protocols for CO 
optimization may be the reason for this result. This needs to be 
re-evaluated if the unusually high use of CVP monitoring has 
any advantage for hemodynamic monitoring during high-risk 
surgery in Korea.
Study limitations
The low response rate (4%) to our survey, causing a high 
likelihood of non-responder bias, was largely due to the 
limitations of our survey method. We believe that the inclusion 
of a large number of incorrect e-mail addresses was the primary 
reason for the low response rate. Thus, it was difficult to estimate 
the denominator population, making it almost impossible to 
correctly estimate the response rate. This is a common weakness 
of e-mail- and web-based surveys [27]. Moreover, the majority 
of respondents practiced at university or general hospitals where 
many high-risk surgeries are performed, suggesting that the 
survey was not of interest to all KSA members. A topic that was 
of interest to only one faction of the target population is likely 
to have contributed to the low response rate [28]. As a result of 
these limitations, our survey respondents are not representative 
of the entire KSA membership; thus, careful con sideration is 
needed when generalizing our findings.
In conclusion, the present study shows that despite a 
relatively high frequency of CO monitoring, many Korean 
anesthesiologists do not frequently optimize it in high-risk 
surgery patients. 
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Appendix
Korean Society of Anesthesiology Hemodynamic Monitoring Questionnaire
Hemodynamic management in patients undergoing high-risk surgery
For the following questionnaire, we will define high risk surgery patients as patients aged 18 years or older presenting for major 
surgery expected to last more than 1.5 hours and having at least two of the following criteria:
1. Cardiac or respiratory illness resulting in functional limitation
2. Extensive surgery planned for carcinoma involving bowel anastomosis
3. Predictable acute massive blood loss (> 2.5 liters)
4. Aged over 70 years with functional limitation of one or more organ systems
5. Septicemia (positive blood cultures or septic focus)
6. Respiratory failure (PaO2 < 60 mmHg on FiO2 > 0.4 i.e. PaO2:FiO2 ratio < 150 mmHg or ventilation > 48 hours) 
7. Acute abdominal catastrophe (e.g. pancreatitis, perforated viscous, gastro-intestinal bleed)
8. Acute renal failure (urea > 20 mmol/L, creatinine > 260 μmol/L)
9. Surgery for abdominal aortic aneurysm
10. Disseminated malignancy
1. If you do not provide or directly supervise anesthesia for this type of patient, please indicate so by filling in the box below. Thank you
□ I do not provide or directly supervise anesthesia for this type of patient.
□ I provide or directly supervise anesthesia for this type of patient.
2. How many times in a typical work week do you provide or directly supervise anesthesia for a high risk surgery patient?
□ Rarely or Never
□ 1 to 5 times a week
□ 6 to 10 times a week
□ More than 11 times a week
3. Which statement best describes your practice setting?
□ University Hospital
□ General Hospital
□ Private Practice
□ Other
Other (please specify) 
4. Does your institution or group have a written protocol, care guide, or statement concerning hemodynamic management in this 
setting?
□ Yes
□ No
□ Unsure or don’t know
5. What hemodynamic monitoring do you routinely use for the management of high risk surgery patients? (please, mark all that apply)
□ Plethysmographic Waveform Variation
□ Global end diastolic volume
□ Central venous pressure
□ Stroke Volume Variation
□ Mixed venous saturation (SvO2)
□ Invasive arterial pressure
□ Central venous saturation (ScvO2)
□ Oxygen delivery (DO2)
□ Pulse Pressure Variation
□ Near infrared spectroscopy
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□ Pulmonary capillary wedge pressure
□ Transesophageal echocardiography
□ Non-invasive arterial pressure
□ Systolic Pressure Variation
□ Cardiac output
6. How frequently do you try to optimize arterial pressure intraoperatively in this setting?
□ Never
□ Less than 5 percent of the time
□ Between 6 and 25 percent of the time
□ Between 26 and 50 percent of the time
□ Between 51 and 75 percent of the time
□ More than 75 percent of the time
7. How frequently do you try to optimize central venous pressure in this setting?
□ Never
□ Less than 5 percent of the time
□ Between 6 and 25 percent of the time
□ Between 26 and 50 percent of the time
□ Between 51 and 75 percent of the time
□ More than 75 percent of the time
8. How frequently do you try to optimize cardiac output in this setting?
□ Never
□ Less than 5 percent of the time
□ Between 6 and 25 percent of the time
□ Between 26 and 50 percent of the time
□ Between 51 and 75 percent of the time
□ More than 75 percent of the time
9. How frequently do you try to optimize central venous oxygen saturation (ScvO2) in this setting?
□ Never
□ Less than 5 percent of the time
□ Between 6 and 25 percent of the time
□ Between 26 and 50 percent of the time
□ Between 51 and 75 percent of the time
□ More than 75 percent of the time
10. How frequently do you try to optimize mixed venous oxygen saturation (SvO2) in this setting?
□ Never
□ Less than 5 percent of the time
□ Between 6 and 25 percent of the time
□ Between 26 and 50 percent of the time
□ Between 51 and 75 percent of the time
□ More than 75 percent of the time
11. How frequently do you try to optimize dynamic parameters of fluid responsiveness (Pulse Pressure Variations, Systolic Pressure 
Variations, Plethysmographic Waveform Variations) in this setting?
□ Never
□ Less than 5 percent of the time
□ Between 6 and 25 percent of the time
□ Between 26 and 50 percent of the time
□ Between 51 and 75 percent of the time
□ More than 75 percent of the time
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12. If you optimize hemodynamics in your high risk surgery patients, when do you do it?
□ Before anesthesia induction
□ After anesthesia induction
□ During surgery
□ In the postoperative period
13. When do you think that hemodynamic optimization is of most value?
□ Before anesthesia induction
□ After anesthesia induction
□ During surgery
□ In the postoperative period
14. Regarding respiratory variations in arterial pulse and/or systolic pressure: how do you measure these indices in the clinical setting?
□ Eyeballing
□ Manual calculation
□ Automatic measurement using specific software
If you use automatic measurement using a dedicated software, please specify which one
15. What technique do you use to monitor cardiac output? (please, mark all that apply)
□ LiDCO Monitor
□ Thoracic bioimpedance
□ Esophageal Doppler
□ Vigileo Monitor
□ Swan Ganz catheter
□ PiCCO Monitor
□ Transesophageal echocardiography
□ Other
Other (please specify)
16. If you do not monitor cardiac output routinely in these patients, what are the main reasons for not monitoring it? (please, mark all 
that apply)
□ I use SvO2 and/or ScvO2 as surrogates for cardiac output monitoring
□ Cardiac output monitoring does not provide any additional clinically relevant information in this setting
□ I use dynamic parameters of fluid responsiveness (Pulse Pressure Variations, Systolic Pressure Variations, Plethysmographic 
Waveform Variations) as surrogates for cardiac output monitoring
□ Available cardiac output monitoring solutions are too invasive
□ Available cardiac output monitoring solutions are unreliable
Reminder:
In this questionnaire we define high risk surgery patients as patients aged 18 years or older presenting for major surgery expected 
to last more than one and a half hours and presenting at least two of the following criteria:
1. Severe cardiac or respiratory illness resulting in severe functional limitation
2. Extensive surgery planned for carcinoma involving bowel anastomosis
3. Predictable acute massive blood loss (> 2.5 liters)
4. Aged over 70 years with functional limitation of one or more organ systems
5. Septicaemia (positive blood cultures or septic focus)
6. Respiratory failure (PaO2 < 60 mmHg on FiO2 > 0.4 i.e. PaO2:FiO2 ratio < 150 mmHg or ventilation >48 hours) 
7. Acute abdominal catastrophe (e.g. pancreatitis, perforated viscous, gastro-intestinal bleed)
8. Acute renal failure (urea > 20 mmol/L, creatinine > 260 μmol/L)
9. Surgery for abdominal aortic aneurysm
10. Disseminated malignancy
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17. What are your indicators for volume expansion in this setting (diagnostic tools)? (please, mark all that apply)
□ Central venous pressure
□ Central venous saturation (ScvO2)
□ Urine output
□ Cardiac ouput
□ Transesophageal echocardiography
□ Mixed venous saturation (SvO2)
□ Pulse Pressure Variation or Systolic Pressure Variation
□ Stroke Volume Variation
□ Pulmonary capillary wedge pressure
□ Plethysmographic Waveform Variation
□ Global end diastolic volume
□ Clinical experience
□ Bloodpressure
18. How do you routinely assess the hemodynamic effects of volume expansion in this setting?
□ Increase in urine output
□ Increase in cardiac output
□ Decrease in stroke volume variation
□ Decrease in pulse pressure variation or systolic pressure variation
□ Increase in blood pressure
□ Increase in mixed venous saturation (SvO2)
□ Decrease in heart rate
□ Decrease in plethysmographic waveform variation
□ Increase in central venous saturation (ScvO2)
19. In your opinion, what best predicts an increase in cardiac output following volume expansion?
□ Central venous pressure
□ Mixed venous saturation (SvO2)
□ Global end diastolic volume
□ Stroke volume variation
□ Transesophageal echocardiography
□ Pulse pressure variation or systolic pressure variation
□ Central venous saturation (ScvO2)
□ Plethysmographic waveform variations
□ Cardiac output
□ Clinical experience
□ Pulmonary capillary wedge pressure
□ Blood pressure
20. What is your first choice solution for volume expansion?
□ Human albumin
□ Hydroxyethyl starch solutions
□ Crystalloids
□ Dextrans
□ Blood derived products
□ Gelatin
21. Do you or your department/group manage these patients in the intensive care unit?
□ Yes
□ No
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22. If not, who manages these patients in the ICU?
□ Critical Care physicians
□ Surgeons
□ Other anesthesiologists
□ Other physicians than anesthesiologists or surgeons
□ Mixed population
23. Do you believe that oxygen delivery to the tissues is of major importance in patients during high risk surgery?
□ Yes
□ No
24. What parameter(s) is (are) involved in oxygen delivery to the tissues?
□ Arterial Pressure
□ Cardiac Output
□ Central venous pressure
□ PaO2
□ SaO2
□ Hemoglobin
25. Do you believe that your current hemodynamic management could be improved?
□ Yes
□ No
26. Which statement best describes you?
□ I am an anesthesiologist predominantly caring for transplant surgery patients
□ I am an anesthesiologist predominantly caring for cardiac surgery patients
□ I am an anesthesiologist predominantly caring for patients not having transplant or cardiac surgery
□ I am an anesthesiologist predominantly practicing intensive care
□ I am an anesthesiologist caring for a variety of patients
□ Other
Other (please specify)
27. Did your training include a fellowship year?
□ Yes
□ No
□ Not applicable
28. If yes, which one(s)?
□ Critical care medicine
□ Pediatric anesthesiology
□ Pain
□ Research
□ Cardiac anesthesiology
□ Other
Other (please specify)
29. When did you finish your training?
□ After the year 2000
□ 1990-1999
□ 1980-1989
□ Prior to 1980
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30. How many intensive care unit beds does your primary hospital have?
□ 7 or less
□ 8 to 10
□ 11 to 15
□ 16 to 20
□ 21 to 30
□ 31 to 40
□ More than 40
31. How many beds does your primary hospital have?
□ 100 or less
□ 101 to 250
□ 251 to 500
□ 501 to 1,000
□ More than 1,000
32. What is the population of your practice location?
□ Less than 10,000
□ 10,000 to 50,000
□ 50,001 to 100,000
□ 100,001 to 500,000
□ More than 500,000
33. In which city (province) is your practice? 
□ Seoul
□ Busan
□ Daegu
□ Incheon
□ Gwangju
□ Daejeon
□ Ulsan
□ Gyeonggi-Do
□ Gangwon-Do
□ Chungcheongbuk-Do
□ Chungcheongnam-Do
□ Jeollabuk-Do
□ Jeollanam-Do
□ Gyeongsangbuk-Do
□ Gyeongsangnam-Do
□ Jeju Special Self-Governing Province
Thank you very much for taking time to answer these questions.
